enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bladder Cancer and Medicare: What’s Covered and What’s Not?

   www.aol.com/bladder-cancer-medicare-covered-not...

   You can choose from 10 different plans, depending on factors like your location and coverage needs. ... Tips for managing expenses for bladder cancer treatment. Several factors affect the cost of ...

3. Pfizer's bladder cancer therapy meets main goal in late-stage ...

   www.aol.com/news/pfizers-bladder-cancer-therapy...

   The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...

4. Bladder cancer - Wikipedia

   en.wikipedia.org/wiki/Bladder_cancer

   Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [47] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]

5. Tumor-homing bacteria - Wikipedia

   en.wikipedia.org/wiki/Tumor-homing_bacteria

   The usage of the live attenuated strain of Mycobacterium Bovis, also known as Bacillus Calmette-Guérin (BCG), is a confirmed treatment for bladder cancer. BCG therapy is done by intravesical instillation (drug administration into the urinary bladder via a catheter) and has been used since 1970 on cancer patients. [5]

6. Gemcitabine - Wikipedia

   en.wikipedia.org/wiki/Gemcitabine

   Gemcitabine treats various carcinomas.It is used as a first-line treatment alone for pancreatic cancer, and in combination with cisplatin for advanced or metastatic bladder cancer and advanced or metastatic non-small cell lung cancer.

7. CG Oncology Touts Encouraging Data From Late-Stage Study Of ...

   www.aol.com/finance/cg-oncology-touts...

   Additionally, 97.3% of patients were free from progression to Muscle Invasive Bladder Cancer (MIBC) at 12 months.” No Grade 3 or greater treatment-related adverse events (TRAEs) or deaths were ...